Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ImmunityBio, NantKwest begin patient dosing in Phase 1 clinical trial of COVID-19 vaccine candidate

expresspharmaOctober 22, 2020

Tag: ImmunityBio , NantKwest , COVID-19 vaccine , SARS-CoV-2

PharmaSources Customer Service